Cargando…
Epigenetic Strategies to Boost Cancer Immunotherapies
Recently, immunotherapeutic approaches have shown impressive responses in a subset of cancer patients. However, the rate of success is low and a large percentage of treated patients do not experience clinical benefits. Therefore, additional strategies are needed to improve responses and select respo...
Autor principal: | Barrero, Maria J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485932/ https://www.ncbi.nlm.nih.gov/pubmed/28545238 http://dx.doi.org/10.3390/ijms18061108 |
Ejemplares similares
-
Aptamer-Based Strategies to Boost Immunotherapy in TNBC
por: Agnello, Lisa, et al.
Publicado: (2023) -
The Stability of the Induced Epigenetic Programs
por: Barrero, Maria J.
Publicado: (2012) -
Manipulation of Glucose Availability to Boost Cancer Immunotherapies
por: Marchesi, Federica, et al.
Publicado: (2020) -
Epigenetic Perspective of Immunotherapy for Cancers
por: Keshari, Sunita, et al.
Publicado: (2023) -
Epigenetic Regulation of the Non-Coding Genome: Opportunities for Immuno-Oncology
por: Barrero, Maria J.
Publicado: (2020)